Skip to content
← Back to this collection

PUBLICATIONS · 33630659

Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Jul 10
First author
Oeffinger KC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Oeffinger KC
      type
      Author
    2. name
      Stratton KL
      type
      Author
    3. name
      Hudson MM
      type
      Author
    4. name
      Leisenring WM
      type
      Author
    5. name
      Henderson TO
      type
      Author
    6. name
      Howell RM
      type
      Author
    7. name
      Wolden SL
      type
      Author
    8. name
      Constine LS
      type
      Author
    9. name
      Diller LR
      type
      Author
    10. name
      Sklar CA
      type
      Author
    11. name
      Nathan PC
      type
      Author
    12. name
      Castellino SM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Oeffinger KC
      type
      Author
    2. name
      Stratton KL
      type
      Author
    3. name
      Hudson MM
      type
      Author
    4. name
      Leisenring WM
      type
      Author
    5. name
      Henderson TO
      type
      Author
    6. name
      Howell RM
      type
      Author
    7. name
      Wolden SL
      type
      Author
    8. name
      Constine LS
      type
      Author
    9. name
      Diller LR
      type
      Author
    10. name
      Sklar CA
      type
      Author
    11. name
      Nathan PC
      type
      Author
    12. name
      Castellino SM
      type
      Author
    bibliography ids
    1. nci-bib-83dab000d1dbac1c4421bec2
    book metadata
    content sha256
    21f0c6383569ac3859eabb69f15eb780180f49ad4dc2da3684f328788d5b7dfe
    document type
    citation
    dois
    1. 10.1200/JCO.20.01186
    electronic publication date
    display
    2021 Feb 25
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33630659
    immutable id
    pubmed:33630659@21f0c6383569ac3859eabb69f15eb780180f49ad4dc2da3684f328788d5b7dfe
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    20
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2266-2275
    volume
    39
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33630659
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      f740f97a3694547f7c7331797275ddea450d5bbf225e45807e78188ae8b9f41e
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Jul 10
      precision
      day
      year
      2021
      publication types
      1. Comparative Study
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33630659/
      title
      Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.

      Preserved source evidence · Not medical advice